Insulet
PODD
#1064
Rank
A$27.18 B
Marketcap
$387.08
Share price
-1.57%
Change (1 day)
49.93%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): A$0.52 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.07 Billion. , an increase over its 2023 earnings that were of A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 A$0.53 B36.72%
2023 A$0.39 B481.9%
2022 A$67.59 M-45.24%
2021 A$0.12 B43.35%
2020 A$86.1 M18.51%
2019 A$72.65 M41.16%
2018 A$51.47 M-711.95%
2017 -A$8.42 Million-56.85%
2016 -A$19.5 Million-79.31%
2015 -A$94.24 Million63.85%
2014 -A$57.52 Million31.04%
2013 -A$43.9 Million-21.96%
2012 -A$56.25 Million
2010 -A$53.65 Million-42.38%
2009 -A$93.1 Million-33.56%
2008 -A$0.15 Billion65.93%
2007 -A$84.45 Million209.75%
2006 -A$27.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$63.56 M-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.15 Billion-127.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.14 B 112.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.35 B 4,986.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.99 B 1,945.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.37 B 1,643.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$19.88 B 3,597.99%๐Ÿ‡บ๐Ÿ‡ธ USA